Recent Blog Articles
5 inflammation-fighting food swaps
Is IBD an underrecognized health problem in minority groups?
Sickle cell disease in newborns and children: What families should know and do
COVID-19 vaccines for children and teens: What we do — and don’t — know
Happy trails: Take a hike, now
Sleep well — and reduce your risk of dementia and death
COVID-19 vaccines and the LGBTQ+ community
Polycystic ovary syndrome and the skin
Dental appliances for sleep apnea: Do they work?
Terrified of needles? That can affect your health
Heart Beat: Safety of bypass drug questioned
Safety of bypass drug questioned
Are you headed for bypass surgery sometime soon? If so, ask your surgeon if he or she plans to use a clotting drug called Trasylol (aprotinin). Two reports suggest that you'd be better off with a safer and cheaper alternative.
Just before bypass surgery, surgeons often administer drugs that increase blood's natural clotting ability. These drugs can minimize blood loss and prevent the need for a transfusion. The choices include two generic drugs, aminocaproic acid and tranexamic acid, and Trasylol. Since it was approved in 1993, Trasylol has been used in thousands of bypass operations.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.Sign Me Up
Already a member? Login ».
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.